Additional file 2 of Efficacy and safety of adrenergic alpha-1 receptor antagonists in older adults: a systematic review and meta-analysis supporting the development of recommendations to reduce potentially inappropriate prescribing

Additional file 2. Reasons for exclusion in full text analysis

Additional file 5 of Efficacy and safety of adrenergic alpha-1 receptor antagonists in older adults: a systematic review and meta-analysis supporting the development of recommendations to reduce potentially inappropriate prescribing

Additional file 5. Additional information on patient characteristics for each study used in the included meta-analyses

Additional file 3 of Efficacy and safety of adrenergic alpha-1 receptor antagonists in older adults: a systematic review and meta-analysis supporting the development of recommendations to reduce potentially inappropriate prescribing

Additional file 3. Summary of characteristics of included studies

Additional file 4 of Efficacy and safety of adrenergic alpha-1 receptor antagonists in older adults: a systematic review and meta-analysis supporting the development of recommendations to reduce potentially inappropriate prescribing

Additional file 4. Summary of patient characteristics of included studies

Additional file 1 of Efficacy and safety of adrenergic alpha-1 receptor antagonists in older adults: a systematic review and meta-analysis supporting the development of recommendations to reduce potentially inappropriate prescribing

Additional file 1. Search terms used in the literature database search

Additional file 1: of Effectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults – a systematic review

Search string search 1 and 2. (DOCX 102 kb

Additional file 4: Table S3. of Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults – a systematic review of reviews and the development of recommendations to reduce inappropriate prescribing

Summary of study findings for the comparison of VKA vs. placebo. Table S4. Summary of study findings for the comparison of VKA vs. antiplatelets. (DOCX 28 kb

Additional file 5: Table S4. of Thiazides in the management of hypertension in older adults – a systematic review

Recommendations developed for thiazide use in adults aged ≥65 years. (DOCX 15 kb

Additional file 4: Table S3. of Thiazides in the management of hypertension in older adults – a systematic review

Summary of study findings. (DOCX 51 kb

Additional file 2: Table S1. of Thiazides in the management of hypertension in older adults – a systematic review

Summary of study characteristics. (DOCX 33 kb